Kura Oncology (KURA) Reiterated at Market Outperform by Citizens on Preclinical Data for KO-7246
Upside potential implied by a substantially higher price target relative to current level.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Upside potential implied by a substantially higher price target relative to current level.
What happened, with direct paths to the underlying reporting
Deutsche Bank assigns a target of $24 for KURA versus a $9.83 posted price, indicating substantial upside; file reflects a target update.
Target: $24
Posted price: $9.83
Analyst firm: Deutsche Bank
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.